Japanese researchers sought to build upon prior studies demonstrating the feasibility of liver resection in geriatric hepatocellular carcinoma patients, particularly in those undergoing major ...
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
[13] The studies included in our review were identified by searching Medline using the following key words: 'hepatocellular carcinoma' or 'HCC' or 'hepatic tumor' or 'liver tumor' or 'hepatic ...
T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...
Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...
Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...
Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.
[56] At 9 months of follow-up, the sustained objective response (European Association for the Study of the Liver [EASL ... for the management of hepatocellular carcinoma (HCC) without curative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback